MedullaX
  • NHS & Policy
  • Government & Funding
  • Regulation & Safety
  • Clinical AI & Diagnostics
  • Workforce
  • UK HealthTech & Deals
  • Digital Health & Interoperability
  • Research & Evidence
Shop

MedullaX is an independent platform covering healthcare, medicine, AI, and digital health, providing clear news, analysis, and explainers for clinicians, professionals, and the public in the UK and worldwide.

  • Facebook
  • Twitter
  • Instagram
  • Pinteres

MedullaX
  • NHS & Policy
  • Government & Funding
  • Regulation & Safety
  • Clinical AI & Diagnostics
  • Workforce
  • UK HealthTech & Deals
  • Digital Health & Interoperability
  • Research & Evidence
Shop
MedullaX

What are You Looking for?

  • Clinical AI & Diagnostics
  • Digital Health & Interoperability
  • Government & Funding
  • NHS & Policy
  • Regulation & Safety
  • Research & Evidence
  • UK HealthTech & Deals
  • Workforce
Home patient safety

patient safety

37 posts
ByMedullax
April 19, 2026

AI vs. Clinicians: Performance in Surgical and Interventional Video Analysis

  • Clinical AI & Diagnostics
ByMedullax
March 4, 2026

Sepsis AI Models in ICU: Assessing Performance Under Real-World Data Shifts

  • Clinical AI & Diagnostics
ByMedullax
March 2, 2026

DHSC Funds New Bone Scanners to Boost Fracture Prevention and Reduce Waiting Lists

  • Government & Funding
ByMedullax
February 27, 2026

AI Scribes Enhance Medication History Accuracy in Clinical Settings

  • Clinical AI & Diagnostics
ByMedullax
February 21, 2026

Norovirus Cases Surge: NHS Reports Highest Winter Levels

  • NHS & Policy
ByMedullax
February 21, 2026

First NHS Mammogram Attendance Reaches Decade High, Boosting Cancer Detection

  • NHS & Policy
ByMedullax
February 16, 2026

Virtual Reality for Chronic Low Back Pain: A Randomised Trial Explores Efficacy

  • Clinical AI & Diagnostics
ByMedullax
February 16, 2026

AI Model Predicts CKD Progression in Type 2 Diabetes Across Diverse Groups

  • Clinical AI & Diagnostics
ByMedullax
February 7, 2026

AI Method Links CXR Evidence to CT Quantification for ILD Diagnosis

  • Clinical AI & Diagnostics
ByMedullax
February 7, 2026

MHRA Highlights Rare NAION Risk with Semaglutide (Wegovy, Ozempic, Rybelsus)

  • Government & Funding
  • Research & Evidence
MedullaX
MedullaX is an independent platform covering healthcare, medicine, AI, and digital health, providing clear news, analysis, and explainers for clinicians, professionals, and the public in the UK and worldwide.
  • About Us
  • Contact Us
  • Terms and Conditions
  • Privacy Policy
  • Cookie Policy
  • Editorial Policy
  • Corrections / Feedback Policy
  • Medical Disclaimer
©️ 2026 — MedullaX. All Rights Reserved.